EUVIMEDEUVIMED entdecken
Crossref

Single-Center Study of Therapeutic Apheresis in 24 Male Patients from the MENA Region: Reduction of Lipids, Inflammatory Markers, Autoantibodies, and Implications for Fatigue, Genetics, and Aging

Charlotte Steenblock iD, Romy Walther iD, Yannick Kok, Philip Mavberg, Mohamad Yaman, Rupert Handgretinger, Yandy Marx Castillo-Aleman iD, Maysoon Al Karam, Stefan R Bornstein

Hormone and Metabolic Research · 01.11.2025 · 57 (11) · 646-652

DOI: 10.1055/a-2678-7739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.11.2025. Verfasst von Charlotte Steenblock und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Autoantibodies, Blood Component Removal, Lipids, Fatigue. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular and metabolic disorders, particularly diabetes and obesity, are highly prevalent in the Middle East and North Africa (MENA) region, exhibiting some of the highest global incidence rates. These conditions significantly increase the severity of infectious diseases, notably COVID-19, leading to a rise in long-COVID cases among affected individuals. Furthermore, the MENA region’s extreme temperatures exacerbate cardiovascular issues by elevating heart rates and blood pressure, increasing dehydration and blood viscosity. Extracorporeal therapies, such as apheresis, effectively reduces plasma lipids and inflammatory markers. Furthermore, apheresis has shown promise in reducing autoantibodies associated to long-COVID. Our previous research indicated that apheresis alleviates symptoms in patients with long-COVID and chronic fatigue syndrome. In this study, we treated 24 male patients from the MENA region suffering from chronic fatigue and/or different metabolic diseases such as diabetes, dyslipidemia, or obesity, using double filtration plasmapheresis. Comprehensive plasma analyses were performed before and after apheresis to assess lipid profiles, inflammatory markers, and autoantibodies, revealing significant changes following the procedure. Genetic analyses on a subgroup of the patients showed no mutations in the LDLR, APOB, APOE, PCSK9, LIPA, and LDLRAP1 genes known to be associated with predispositions to monogenic lipid disorders. However, all patients in this subgroup demonstrated an intermediate to high likelihood that their elevated lipid levels have a polygenic basis. These findings suggest that implementing apheresis in the MENA region could significantly improve health outcomes and life expectancy for affected individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesBlood Component RemovalLipidsFatigueAgingCOVID-19HumansMaleMiddle AgedAdultBiomarkersMiddle EastInflammationSARS-CoV-2Aged

Substanzen

AutoantibodiesBiomarkersLipids

Autor:innen und Institutionen

  • Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Ayus Laboratories AG, Horgen, Switzerland.
  • Ayus Medical Group, Inuspheresis Center Basel, Basel, Switzerland.
  • Nesmah Technology, Dubai, United Arab Emirates.
  • Department of Haematology and Oncology, University Children's Hospital, Eberhard Karls Universität Tübingen, Tübingen, Germany.
  • Abu Dhabi Stem Cells Center (ADSCC), Abu Dhabi, United Arab Emirates.

ORCID-Profile: Charlotte Steenblock, Romy Walther, Yandy Marx Castillo-Aleman

Zitieren

APA

Steenblock, C., Walther, R., Kok, Y., Mavberg, P., Yaman, M., Handgretinger, R., Castillo-Aleman, Y. M., Al Karam, M., & Bornstein, S. R. (2025). Single-Center Study of Therapeutic Apheresis in 24 Male Patients from the MENA Region: Reduction of Lipids, Inflammatory Markers, Autoantibodies, and Implications for Fatigue, Genetics, and Aging. Hormone and Metabolic Research, 57(11), 646-652. https://doi.org/10.1055/a-2678-7739

Vancouver

Steenblock C, Walther R, Kok Y, Mavberg P, Yaman M, Handgretinger R, et al. Single-Center Study of Therapeutic Apheresis in 24 Male Patients from the MENA Region: Reduction of Lipids, Inflammatory Markers, Autoantibodies, and Implications for Fatigue, Genetics, and Aging. Hormone and Metabolic Research. 2025;57(11):646-652. doi:10.1055/a-2678-7739

BibTeX
@article{Steenblock2025,
  author = {Steenblock, Charlotte and Walther, Romy and Kok, Yannick and Mavberg, Philip and Yaman, Mohamad and Handgretinger, Rupert and Castillo-Aleman, Yandy Marx and Al Karam, Maysoon and Bornstein, Stefan R},
  title = {Single-Center Study of Therapeutic Apheresis in 24 Male Patients from the MENA Region: Reduction of Lipids, Inflammatory Markers, Autoantibodies, and Implications for Fatigue, Genetics, and Aging},
  journal = {Hormone and Metabolic Research},
  year = {2025},
  volume = {57},
  number = {11},
  pages = {646--652},
  doi = {10.1055/a-2678-7739}
}
Kostenlos starten →